{
  "ptid_time": "068_S_0476_2006-07-12",
  "img_path": "/data/qiuhui/data/adni/images/068_S_0476/2006-07-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 30,916 mm³, 10.1% above the reference mean. With a Z-score of 0.23 (59.2th percentile), this represents normal volume ; hippocampal volume measures 6,140 mm³, 13.7% below the reference mean. With a Z-score of -1.26 (10.4th percentile), this represents mild atrophy; whole brain volume measures 870,528 mm³, 10.7% below the reference mean. With a Z-score of -1.34 (8.9th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,671 mm³, 0.1% below the reference mean. With a Z-score of -0.00 (49.9th percentile), this represents normal volume ; fusiform gyrus volume measures 13,972 mm³, 17.9% below the reference mean. With a Z-score of -1.63 (5.2th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 14,655 mm³, 23.5% below the reference mean. With a Z-score of -2.04 (2.0th percentile), this represents significant atrophy. ",
  "text_data": "Age is 75.8 years. Gender is Female. Education: 14 years. Handedness: Right. Race: White. Medical history: Neurologic; Cardiovascular; Musculoskeletal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 26.0. Logical Memory: 1.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 477.60 pg/mL (mild reduced); Total tau: 347.00 pg/mL (mild elevated); Phosphorylated tau: 36.47 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild to moderate atrophy in key Alzheimer's-related regions (hippocampus, fusiform gyrus, middle temporal gyrus) alongside biomarker evidence of amyloidopathy (Aβ reduction) and tauopathy (elevated T-tau/P-tau). The MMSE of 26 is borderline, but structural and biomarker findings suggest early neurodegenerative changes.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s given biomarker profile).  \n**Confidence:** **Medium** (clinical correlation needed to rule out other causes of atrophy/biomarker changes).  \n\n*Note: Progression to dementia is likely if atrophy/biomarkers worsen on follow-up.*",
  "timestamp": "2025-07-26T08:49:46.326336"
}